Blue Owl Capital supports $4bn acquisition of PCI Pharma Services

Blue Owl Capital supports $4bn acquisition of PCI Pharma Services

Blue Owl Capital backed the $4bn acquisition of PCI Pharma Services, a leading provider of pharmaceutical packaging and clinical trial solutions. The deal was led by Kohlberg & Company, with Blue Owl providing strategic financing to support the transaction. PCI...
Sallyport closes $160m inaugural PE fund, exceeding target

Sallyport closes $160m inaugural PE fund, exceeding target

Texas-based Sallyport Investments closed its first private equity fund at $160m, surpassing its original target. The fund focuses on investing in lower middle-market companies across North America. Key sectors include healthcare, business services, and industrials,...